Development

Beverly Nickerson, PhD, is an associate research fellow in analytical research and development at Pfizer Inc., Eastern Point Road, Mail Stop 4086, Groton, CT 06340, tel. 860.441.0668, fax 860.715.8004, beverly_nickerson@groton.pfizer.com.

Anster Charles was a graduate student at the University of Missouri’s Chemistry Department, Columbia, MO.

Carlos Lee works for Lyndra Therapeutics, Watertown, MA.

Gail Johnson works for Pfizer Worldwide Research and Development in Groton, CT.

John Warzeka works for Pfizer Worldwide Research and Development in Groton, CT.

Articles

Laboratory testing found that a novel approach reduced the time required for sample preparation from hours to minutes. This article summarizes test methods and results.

Speeding Sample Preparation and API Extraction from Solid Oral Dosage Formulations

JÃ©rÃ´me Revel is senior development engineer at Recipharm.

Philippe Gorria is senior director of Pharmaceutical Development at Recipharm.

Modified-release oral dosage forms can offer benefits to both formulation scientists and patients.

Modified-Release Formulations: Improving Efficacy and Patient Compliance

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Understanding the API, delivery mechanism, and excipient functionality is essential to solving drug solubility challenges.


Strategic Screening for Solubility Solutions

Yasvanth Ashokraj works in Integrated Product Development at CIPLA.

Prashant Modak works in Integrated Product Development at CIPLA.

Kalpesh Sawant work in Integrated Product Development at CIPLA.

Praveen Date works in Integrated Product Development at CIPLA.

Swati Laud works in Integrated Product Development at CIPLA.

This article demonstrates how qualitative physical attributes testing can be used to characterize soft gel capsule rupture/disintegration during rectal administration.

Evaluating a New Quality Control Test for Soft Gelatin Rectal Capsules

The company’s planned investment in its alkoxylation facility in the United States Gulf Coast will also expand production capacity for its polyethylene glycols.

Dow Expands Capacity for Polyethlene Glycols

Lonza’s Capsugel Colorista capsule R&D solution can cut overall development time and offers greater flexibility during technical color development.

New Capsule R&D Solution

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Innovative technologies, such as drug-loaded devices and 3D printing, enable advances in implantable devices and other novel dosage forms.

New Dose Forms Focus on the Patient

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Lipid-based formulations offer a means of addressing the physicochemical and biological challenges of poorly soluble APIs.

Developing Lipid-Based Formulations

Susan Haigney is lead editor of Pharmaceutical Technology and Pharmaceutical Technology Europe.

Industry experts discuss the formulation and development issues that should be considered when addressing scale up from small-scale batches to commercial production.

Outsourcing Development: Small-Scale to Commercial

Omya will showcase Omyapharm 500-OG (calcium carbonate and tribasic calcium phosphate) at CPhI Worldwide in Madrid, Spain, on Oct. 9–11, 2018.

Formulation and Drug Delivery, Solid Dosage